Inhibits bladder cancer proliferation by negatively regulating glutaminase, glutamate, and αketoglutarate expression. Overexpression of glutaminase rescues inhibition of lincRNAp21 on bladder cancer survival. This evidence concerns the gene GLS and urinary bladder carcinoma.